Part 2 - SCHEDULING OF DANGEROUS DRUGS

Section 50-32-201 - General criteria to be considered
Section 50-32-202 - Designation of drug as dangerous drug
Section 50-32-203 - Effect of rescheduling under federal law
Section 50-32-204 - Immediate precursors
Section 50-32-205 - Nonprescription drugs not to be scheduled
Section 50-32-206 - Use of names of scheduled drugs
Section 50-32-207 - Order forms for drugs in Schedules I and II
Section 50-32-208 - Prescription and medical requirements for scheduled drugs - penalty
Section 50-32-209 - Republication of schedules
Section 50-32-210 through 50-32-220 - Reserved
Section 50-32-221 - Criteria for placement of drug in Schedule I
Section 50-32-222 - Specific dangerous drugs included in Schedule I
Section 50-32-223 - Criteria for placement of drug in Schedule II
Section 50-32-224 - Specific dangerous drugs included in Schedule II
Section 50-32-225 - Criteria for placement of drug in Schedule III
Section 50-32-226 - Specific dangerous drugs included in Schedule III
Section 50-32-227 - Board authorized to exempt certain compounds, mixtures, or preparations from Schedule III
Section 50-32-228 - Criteria for placement of drug in Schedule IV
Section 50-32-229 - Specific dangerous drugs included in Schedule IV
Section 50-32-230 - Board authorized to exempt certain compounds, mixtures, or preparations from Schedule IV
Section 50-32-231 - Criteria for placement of drug in Schedule V
Section 50-32-232 - Specific dangerous drugs included in Schedule V
Section 50-32-233 - Exempt anabolic steroid products